1. Home
  2. KPTI vs BSBK Comparison

KPTI vs BSBK Comparison

Compare KPTI & BSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • BSBK
  • Stock Information
  • Founded
  • KPTI 2008
  • BSBK 1893
  • Country
  • KPTI United States
  • BSBK United States
  • Employees
  • KPTI N/A
  • BSBK N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • BSBK Banks
  • Sector
  • KPTI Health Care
  • BSBK Finance
  • Exchange
  • KPTI Nasdaq
  • BSBK Nasdaq
  • Market Cap
  • KPTI 90.7M
  • BSBK 102.6M
  • IPO Year
  • KPTI 2013
  • BSBK N/A
  • Fundamental
  • Price
  • KPTI $0.62
  • BSBK $7.73
  • Analyst Decision
  • KPTI Strong Buy
  • BSBK
  • Analyst Count
  • KPTI 4
  • BSBK 0
  • Target Price
  • KPTI $5.00
  • BSBK N/A
  • AVG Volume (30 Days)
  • KPTI 676.1K
  • BSBK 6.0K
  • Earning Date
  • KPTI 02-27-2025
  • BSBK 02-14-2025
  • Dividend Yield
  • KPTI N/A
  • BSBK N/A
  • EPS Growth
  • KPTI N/A
  • BSBK N/A
  • EPS
  • KPTI N/A
  • BSBK N/A
  • Revenue
  • KPTI $148,442,000.00
  • BSBK $12,132,417.00
  • Revenue This Year
  • KPTI $5.47
  • BSBK N/A
  • Revenue Next Year
  • KPTI $6.33
  • BSBK N/A
  • P/E Ratio
  • KPTI N/A
  • BSBK N/A
  • Revenue Growth
  • KPTI 1.77
  • BSBK N/A
  • 52 Week Low
  • KPTI $0.58
  • BSBK $6.40
  • 52 Week High
  • KPTI $1.95
  • BSBK $8.66
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 40.06
  • BSBK 47.93
  • Support Level
  • KPTI $0.65
  • BSBK $7.67
  • Resistance Level
  • KPTI $0.70
  • BSBK $8.00
  • Average True Range (ATR)
  • KPTI 0.05
  • BSBK 0.28
  • MACD
  • KPTI -0.00
  • BSBK -0.01
  • Stochastic Oscillator
  • KPTI 11.00
  • BSBK 53.33

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About BSBK Bogota Financial Corp.

Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey.

Share on Social Networks: